The latent structure and comorbidity patterns of generalized anxiety disorder and major depressive disorder: A national study

Depression and Anxiety

Volumn 31, Issue 3, 2014, Pages 214-222

  Blanco, Carlos ^a,b,d   Rubio, José M ^a   Wall, Melanie ^a,b   Secades Villa, Roberto ^a   Beesdo Baum, Katja ^c   Wang, Shuai ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Department of Biostatistics Mailman School of Public Health Columbia University ^*  (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d Department of Psychiatry College of Physicians and Surg of Columbia University ^*  (United States)

Author keywords

anxiety anxiety disorders; epidemiology; factor analysis; mood disorders; nosology

Indexed keywords

ADULT; AFRICAN AMERICAN; ALCOHOL USE DISORDER; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; COMORBIDITY; CONDUCT DISORDER; DRUG DEPENDENCE; DSM-IV; DYSTHYMIA; EDUCATIONAL STATUS; EXPLORATORY RESEARCH; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; INCOME; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PANIC; PATHOLOGICAL GAMBLING; PERSONALITY DISORDER; PREVALENCE; PRIORITY JOURNAL; SOCIAL PHOBIA; UNEMPLOYMENT; UNITED STATES; YOUNG ADULT; ADOLESCENT; AGED; ANXIETY DISORDERS; CLASSIFICATION; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FACTORIAL ANALYSIS; HEALTH SURVEY; MIDDLE AGED; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 84895918106     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22139     Document Type: Article

References (48)

1. World Health Organization. World health report 2001: Mental health: New understanding, new hope. Geneva, Switzerland: World Health Organization; 2001.
2. Hettema JM,. The nosologic relationship between generalized anxiety disorder and major depression. Depress Anxiety 2008; 25: 300-316.
3. Hasin DS, Goodwin RD, Stinson FS, Grant BF,. Epidemiology of major depressive disorder: Results from the national epidemiologic survey on alcoholism and related conditions. Arch Gen Psychiatry 2005; 62: 1097-1106.
4. Hettema JM, Neale MC, Kendler KS,. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001; 158: 1568-1578.
5. Horwath E, Wolk SI, Goldstein RB, et al. Is the comorbidity between social phobia and panic disorder due to familial cotransmission or other factors? Arch Gen Psychiatry 1995; 52: 574-582.
6. Conway KP, Compton W, Stinson FS, Grant BF,. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2006; 67: 247-257.
7. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ,. Major depression and generalized anxiety disorder: same genes, (partly) different environments? Arch Gen Psychiatry 1992; 49: 716-722.
8. Middeldorp CM, Birley AJ, Cath DC, et al. Familial clustering of major depression and anxiety disorders in Australian and Dutch twins and siblings. Twin Res Hum Genet 2005; 8: 609-615.
9. Kendler KS, Gardner CO, Gatz M, Pedersen NL,. The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med 2007; 37: 453-462.
10. Beesdo K, Pine DS, Lieb R, Wittchen HU,. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry 2010; 67: 47-57.
11. Kessler RC, Gruber M, Hettema JM, Hwang I, Sampson N, Yonkers KA,. Co-morbid major depression and generalized anxiety disorders in the national comorbidity survey follow-up. Psychol Med 2008; 38: 365-374.
12. Moffitt TE, Caspi A, Harrington H, et al. Generalized anxiety disorder and depression: Childhood risk factors in a birth cohort followed to age 32. Psychol Med 2007; 37: 441-452.
13. Krueger RF,. The structure of common mental disorders. Arch Gen Psychiatry 1999; 56: 921-926.
14. Slade T, Watson D,. The structure of common DSM-IV and ICD-10 mental disorders in the Australian general population. Psychol Med 2006; 36: 1593-1600.
15. Vollebergh WAM, Iedema J, Bijl RV, de Graaf R, Smit F, Ormel J,. The structure and stability of common mental disorders: the nemesis study. Arch Gen Psychiatry 2001; 58: 597-603.
16. Beesdo B, Höfler M, Gloster AT, et al. The structure of common mental disorders: a replication study in a community sample of adolescents and young adults. Int J Methods Psychiatr Res 2009; 18: 204-220.
17. Wittchen HU B-BK, Gloster AT, Höfler M, et al. The structure of mental disorders re-examined: Is it developmentally stable and robust against additions? Int J Methods Psychiatr Res 2009; 18: 189-203.
18. Naragon-Gainey K,. Meta-analysis of the relations of anxiety sensitivity to the depressive and anxiety disorders. Psychol Bull 2010; 136: 128-150.
19. Grant BF, Kaplan K, Shepard J, Moore T,. Source and accuracy statement for wave 1 of the 2001-2002 national epidemiologic survey on alcohol and related conditions. Bethesda, MD: National Institute on Alcohol Abuse and Acoholism; 2003.
20. Grant BF, Goldstein RB, Chou SP, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the wave 2 national epidemiologic survey on alcohol and related conditions. Mol Psychiatry 2008; 14: 1051-1066.
21. Grant B DD, Hasin D,. The Alcohol Use Disorder and Associated Disabilites. The alcohol use disorder and associated disabilites schedule DSM-IV version. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2001.
22. Grant BF, Dawson DA, Stinson FS, Chou PS, Kay W, Pickering R,. The alcohol use disorder and associated disabilities interview schedule-iv (audadis-iv): Reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend 2003; 71: 7-16.
23. Ruan WJ, Goldstein RB, Chou SP, et al. The Alcohol Use Disorder And Associated Disabilities Interview Schedule-Iv (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend 2008; 92: 27-36.
24. Zimmerman M,. Diagnosing personality disorders: a review of issues and research methods. Arch Gen Psychiatry 1994; 51: 225-245.
25. Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the United States results from the national epidemiologic survey on alcohol and related conditions. Psychol Med 2005; 35: 1747-1759.
26. Canino G, Bravo M, Ramírez R, et al. The Spanish alcohol use disorder and associated disabilities interview schedule (AUDADIS): eeliability and concordance with clinical diagnoses in a hispanic population. J Stud Alcohol 1999; 60: 790-799.
27. Research Triangle Institute. Software for survey data analysis (Sudaan) version 9.0.3. Research Triangle Park (NC); 2007.
28. Muthen LK, Muthen BO,. Mplus user's guide. Los Angeles: Muthen & Muthen; 1998-2006.
29. Bentler PM, Bonett DG,. Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bull 1980; 88: 588-606.
30. Reise SP, Morizot J, Hays RD,. The role of the bifactor model in resolving dimensionality issues in health outcomes measures. Qual Life Res 2007; 16 (Suppl 1): 19-31.
31. Iza M, Wall, MM, Heimberg, RG, et al. Latent structure of social fears and social anxiety disorders. Psychol Med 2013; In press.
32. Kim E, Yoon M, Lee T,. Testing measurement invariance using mimic: likelihood ratio test with a critical value adjustment. Educ Psychol Meas 2011; 71: 1-24.
33. Finch H,. The mimic model as a method for detecting dif: comparison with mantel-haenszel, sibtest, and the irt likelihood ratio. App Psychol Meas 2005; 29: 278-295.
34. Oort FJ,. Simulation study of item bias detection with restricted factor analysis. Struct Equ Modeling 1998; 5: 107-124.
35. Wang WC, Shih CL, Yang CC,. The mimic method with scale purification for detecting differential item functioning. Educ Psychol Meas 2009; 69: 713-731.
36. Stark S, Chernyshenko OS, Drasgow F,. Detecting differential item functioning with confirmatory factor analysis and item response theory: toward a unified strategy. J Appl Psychol 2006; 91: 1292-1306.
37. Vesga-Lopez O, Schneier FR, Wang S, et al. Gender differences in generalized anxiety disorder: results from the national epidemiologic survey on alcohol and related conditions (NESARC). J Clin Psychiatry 2008; 69: 1606-1616.
38. Wittchen HU, Zhao S, Kessler RC, Eaton WW,. DSM-III-R generalized anxiety disorder in the national comorbidity survey. Arch Gen Psychiatry 1994; 51: 355-364.
39. Kessler RC, Nelson CB, McGonagle KA, Liu J,. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the us national comorbidity survey. Br J Psychiatry 1996; 168: 17-30.
40. Mathew A, Pettit J, Lewinsohn P, Seeley J, Roberts R,. Co-morbidity between major depressive disorder and anxiety disorders: shared etiology or direct causation? Psychol Med 2011; 41: 2023-2034.
41. Parker G, Hadzi-Pavlovic D,. Is the female preponderance in major depression secondary to a gender difference in specific anxiety disorders? Psychol Med 2004; 34: 461-470
42. Merikangas KR, Zhang H, Avenevoli S, Acharyya S, Neuenschwander M, Angst J,. Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich cohort study. Arch Gen Psychiatry 2003; 60: 993-1000.
43. Kupfer DJ, First MB, Regier DA,. A research agenda for DSM-V. Washington, D.C.: American Psychiatric Association; 2002.
44. Charney DS, Grillon C, Bremner JD,. Review: the neurobiological basis of anxiety and fear: circuits, mechanisms, and neurochemical interactions (Part I). Neuroscientist 1998; 4: 35-44.
45. Milak MS, Parsey RV, Keilp J, Oquendo MA, Malone KM, Mann JJ,. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry 2005; 62: 397-408.
46. Reinhold JA, Mandos LA, Rickels K, Lohoff FW,. Pharmacological treatment of generalized anxiety disorder. Exp Opin Pharmacother 2011; 12: 2457-2467.
47. Gelenberg A,. A review of the current guidelines for depression treatment. J Clin Psychiatry 2010; 71: e15.
48. Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a star* d report. Am J Psychiatry 2008; 165: 342-351.